Acyclovir in immunocompromised patients with cytomegalovirus disease
Authors:
- Henry H. BalfourHBHenry H. Balfour
- Bonnie BeanBBBonnie Bean
- Charles D. MitchellCMCharles D. Mitchell
- Gregory W. SachsGSGregory W. Sachs
- James R. BoenJBJames R. Boen
- Charlene K. EdelmanCECharlene K. Edelman
- 1 July 1982
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 73 (1) , 241-248
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Acyclovir Prophylaxis of Herpes-Simplex-Virus InfectionsNew England Journal of Medicine, 1981
- ACYCLOVIR THERAPY FOR MUCOCUTANEOUS HERPES SIMPLEX INFECTIONS IN IMMUNOCOMPROMISED PATIENTSThe Lancet, 1981
- CONTROLLED CLINICAL TRIAL OF INTRAVENOUS ACYCLOVIR IN HEART-TRANSPLANT PATIENTS WITH MUCOCUTANEOUS HERPES SIMPLEX INFECTIONSThe Lancet, 1981
- Therapy of Experimental Herpes Simplex Encephalitis with Aciclovir in MiceAntimicrobial Agents and Chemotherapy, 1979
- Growth Inhibition by Acycloguanosine of Herpesviruses Isolated from Human InfectionsAntimicrobial Agents and Chemotherapy, 1979
- 9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes groupNature, 1978
- CYTOMEGALOVIRUS INFECTION AMONG RENAL ALLOGRAFT RECIPIENTSActa Medica Scandinavica, 1969
- The Clinical Significance of Cytomegalovirus Infection in Renal Transplant RecipientsAnnals of Internal Medicine, 1967
- Cytomegalovirus infection and cytomegalic inclusion disease in renal homotransplant recipientsThe American Journal of Medicine, 1966
- Infectious Pulmonary Disease in Patients Receiving Immunosuppressive Therapy for Organ TransplantationNew England Journal of Medicine, 1964